Cite
MLA Citation
V Pengo et al.. “Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.” Lupus, vol. 25, 2016, pp. 301–306. http://access.bl.uk/ark:/81055/vdc_100063090439.0x000027